Aug. 30, 2026 — Bayer has announced the presentation of first detailed results from the Phase III REVEAL study, an ...
Aug. 31, 2026 — At the European Society of Cardiology Congress in Munich, Abbott announced new late-breaking 12-month ...
Aug. 28, 2026 — Royal Philips and Imricor Medical Systems have announced a new Interventional MR (iMR) lab solution for ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
Aug. 26, 2026 – The Cardiovascular Research Foundation (CRF) announced the late-breaking clinical trials and science ...
Aug. 31, 2026 — A new heart failure (HF) treatment effect calculator could help overcome one of the largest barriers to ...
Aug. 28, 2026 — GE HealthCare has announced three additions to its Vivid cardiovascular ultrasound portfolio — Vivid ...
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
Aug. 28, 2026 — Heartflow, Inc. has announced late-breaking one-year results from an independent randomized clinical ...
Aug. 28, 2026 — At ESC Congress in Munich, the European Society of Cardiology released its first updated heart failure ...
Aug. 18, 2026 —The board of trustees of the Radiological Society of North America's (RSNA) Research & Education (R&E) ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
Aug. 27, 2026 — NYU Langone Health has appointed Sunil Rao, MD, an internationally recognized clinician-investigator ...
Aug. 21, 2026 — Milestone Pharmaceuticals Inc. has announced that the first patient has been enrolled in the Phase 3 ...
Aug. 25, 2025 — Abbott has received CE Mark in Europe for the Esprit BTK Everolimus Eluting Resorbable Scaffold ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
Aug. 26, 2026 — Element Science, the creator of the Jewel Patch Wearable Cardioverter Defibrillator (Patch-WCD) to ...
Aug. 24, 2026 — The VIVA Foundation will spotlight the latest advances in vascular medicine as 26 clinical trials are ...
Aug. 24, 2026 — Tempus AI, Inc. has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for ...
September 02, 2026
